| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On June 12, 2024, Ocular Therapeutix, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting"). At the 2024 Annual Meeting, the Company's stockholders approved an amendment ("Amendment No. 3") to the Company's 2021 Stock Incentive Plan, as amended (the "2021 Stock Incentive Plan"). Amendment No. 3, which had previously been adopted by the Company's Board of Directors subject to stockholder approval, increased the number of shares of common stock of the Company issuable under the 2021 Stock Incentive Plan by 7,000,000 shares.
A description of the material terms and conditions of Amendment No. 3 is set forth in Proposal 3 on pages 39 to 51 of the Company's definitive proxy statement for the 2024 Annual Meeting, filed with the Securities and Exchange Commission on April 29, 2024, and is incorporated herein by reference. This summary of Amendment No. 3 is qualified in its entirety by reference to the full text of the 2021 Stock Incentive Plan, as amended by Amendment No. 3, a copy of which is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Attachments
Disclaimer
Ocular Therapeutix Inc. published this content on 14 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2024 13:05:27 UTC.